Peter C. Richardson - Feb 2, 2023 Form 4 Insider Report for Mallinckrodt plc (MNK)

Role
EVP & Chief Scientific Officer
Signature
/s/ Mark Tyndall, Attorney-in-Fact
Stock symbol
MNK
Transactions as of
Feb 2, 2023
Transactions value $
$0
Form type
4
Date filed
2/3/2023, 12:31 PM
Previous filing
Jan 20, 2023
Next filing
Apr 5, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MNK Ordinary Shares Award $0 +75.1K $0.00 75.1K Feb 2, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported ordinary shares represent restricted stock units, which will be settled in an equal number of MNK ordinary shares and will vest ratably on each of the first three anniversaries of January 12, 2023.

Remarks:

This Form 4 constitutes a notice to the Issuer for purposes of Part V of the Companies Act 2014